4Filing Date: Apr 30, 2026
HCA Healthcare
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001193125-26-197746
Total Value$0
Trades1
Insiders1
Transaction Details
DEPARLE NANCY ANN
Director·Direct
Grant · Acquire
Common Stock
Shares+509
Price$0.00
Total Value$0
Shares Owned After21.91K
Transaction DateApr 28, 2026
Footnotes ▸
Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date.
Post-Transaction Holdings
DEPARLE NANCY ANN · Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 21.91K | +509 (2.38%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-04-28
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: HCA Healthcare, Inc. (HCA)
CIK: 0000860730
--- Reporting Owner ---
Name: DEPARLE NANCY ANN
CIK: 0001144511
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-04-28 | Code: A (Grant or award)
Shares: +509 | Price: $0.00
Shares Owned After: 21,910 | Ownership: D (Direct)
Footnotes:
[F1] Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date.
--- Footnotes (Complete Index) ---
F1: Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date.
--- Signature ---
/s/ /s/ Kevin A. Ball, Attorney-in-Fact (2026-04-30)